Cerebral vasospasm following aneurysmal subarachnoid hemorrhage

Stroke

Volumn 16, Issue 4, 1985, Pages 562-572

  Kassell, N F ^a   Sasaki, T ^a   Colohan, A ^a   Nazar, G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM; ETIOLOGY; HUMAN; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; SHORT SURVEY; SUBARACHNOID HEMORRHAGE;

ANTI-INFLAMMATORY AGENTS; CALCIUM CHANNEL BLOCKERS; CEREBRAL ANGIOGRAPHY; CONFUSION; CONSCIOUSNESS DISORDERS; EPOPROSTENOL; HEADACHE; HUMAN; HYPERTENSION; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; STREPTOKINASE; SUBARACHNOID HEMORRHAGE; TEPROTIDE; THROMBOXANE-A SYNTHASE; ULTRASONOGRAPHY; VASCULAR RESISTANCE; VITAMIN E;

EID: 0021873601     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.16.4.562     Document Type: Article

References (217)

1. Kassell NF, Drake CG: Timing of aneurysm surgery. Neurosurgery 10: 514-519, 1982
2. Kassell NF, Drake CG: Review of the management of saccular aneurysms. Neurological Clinics of North America 1: 73-86, 1983
3. Walker MD, Chap XXI-1 Brain and peripheral nervous system tumors in Holland and Frei (eds) Cancer Medicine. Phila: Lee & Ferberger, 1982, p 1603
4. Matsumoto N, Whisnant JP, Kurland LT, Okazaki H: Natural history of stroke in Rochester, Minnesota, 1955 through 1969: An extension of a previous study, 1945 through 1954. Stroke 4: 20-29, 1972
5. Sacco RL, Wolf PA, Kannel WB, McNamara PM: Survival and recurrence following stroke - The Framingham study. Stroke 13: 290-295, 1982
6. Graf CJ, Nibbelink DW: Cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Stroke 5: 559-610, 1974
7. Saito I, Sano K: Vasospasm after aneurysm rupture: Incidence, onset, and course. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 294-301
8. Bergvall U, Galera R: Time relationship bet ween subarachnoid hemorrhage, arterial spasm, changes in cerebral circulation and posthemorrhagic hydrocephalus. Acta Radiol (Diagn) 9: 229-237, 1969
9. Kwak R, Niizuma H, Ohi T, Suzuki J: Angiographic study of cerebral vasospasm following rupture of intracranial aneurysms: Part 1. Time of appearance. Surg Neurol 11: 257-262, 1979
10. Weir B, Grace M, Hansen J, Rothberg C: Time course of vasospasm in man. J Neurosurg 48: 173-178, 1978
11. Kågstrom E, Greitz T, Hanson J, Galera R: Changes in cerebral blood flow after subarachnoid hemorrhage. In deVet AC (ed): Proceedings of the Third International Congress of Neurological Surgery, Amsterdam, Excerpta Medica Foundation, 1965, pp 629-633
12. Allcock JM, Drake CG: Ruptured I-C Aneurysms: the role of arterial spasm. J Neurosurg 22: 21-29, 1965
13. OdomGL: Cerebral vasospasm. Clin Neurosurg 22: 29-58, 1975
14. Fletcher TM, Taveras JM, Pool JL: Cerebral vasospasm in angiography for intracranial aneurysms: Incidence and significance in one hundred consecutive angiograms. Arch Neurol 1: 38-47, 1959
15. Fisher CM, Robertson GH, Ojemann RG: Cerebral vasospasm with ruptured saccular aneurysm. The clinical manifestations Neurosurgery 1: 245-248, 1977
16. Sundt TM Jr, Whisnant JP: Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease. N Engl J Med 299: 116-122, 1978
17. Post KD, Flamm ES, Goodgold A, RansohoffJ: Ruptured intracranial aneurysms. Case morbidity and mortality. J Neurosurg 46: 290-295, 1977
18. Nibbelink DW, Torner JC, Henderson WG: Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke 6: 622-629, 1975
19. Kodama N, Mizoi K, Sakurai Y, Suzuki J: Incidence and onset of vasospasm. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 361-365
20. Harders A, Gilsbach J: Transcranial Doppler sonography. Ultrascharh Med 5 (5): 237-245, 1984
21. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. J Neurosurg 8: 660-667, 1951
22. Weir B, Erasmo R, Miller J, Mclntyre J, Secord S, Milke B: Vasospasm in response to repeated subarachnoid hemorrhage in the monkey. J Neurosurg 33: 395-406, 1970
23. Grady PA, Blaumanis OR, Nelson ER: Morphology and flow dynamics of focal arterial constriction. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 107-112
24. Nelson E, Geitz SD, Rennels ML, Forbes MS, Kawamura J: Scanning transmission electron microscopic studies of arterial endothelium following experimental vascular occlusion. In Cervos-Navarro J, Betz E, Mistokos F, Willenweber R (eds) The Cerebral Vessel Wall. New York: Raven Press, 1976, pp 33-39
25. Sasaki T, Kassell NF, Yamashita M, Fujiwara S: Disturbances of blood-brain barrier and cerebral arterial permeability following experimental subarachnoid hemorrhage. XIIth Annual Meeting of the Society of Neurosurgical Anesthesia and Neurologic Supportive Care, pp 20-22, 1984
26. Fein JM, Flor WJ, Cohan SL, Parkhurst J: Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries. J Neurosurg 41: 49-58, 1974
27. Alksne JF, Smith RW: Experimental models of spasm. Clin Neurosurg 24: 216-227, 1977
28. Simeone FA, Ryan KG, Cotter JR: Prolonged experimental cerebral vasospasm. J Neurosurg 29: 357-366, 1968
29. Tanabe Y, Sakata K, Yamada H, Ito T, Takada M: Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. J Neurosurg 49: 229-238, 1978
30. Joris I, Majno G: Endothelial changes induced by arterial spasm Am J Pathol 102: 346-358, 1981
31. Mizukami M, Kin H, Araki G, Mihara H, Yoshida Y: Is angiographic spasm real spasm? Acta Neurochir (Wien) 34: 247-259, 1976
32. Smith RR, Clower BR, Peeler DF Jr, Yoshioka J: The angiopathy of subarachnoid hemorrhage: Angiographic and morphologic correlates. Stroke 14: 240-245, 1983
33. Clower BR. Haining JL, Smith RR: Pathophysiological changes in the cerebral artery after subarachnoid hemorrhage. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 124-131
34. Hughes JT, Schianchi PM: Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48: 515-525, 1978
35. Tani E, Yamagata S, Ito Y: Intercellular granules and vesicles in prolonged cerebral vasospasm. J Neurosurg 48: 179-189, 1978
36. Hoshi T, Shimizu T, Kito K, Yamasaki N, Takahaski K, Takahashi M, Okada T, Kasuya H, Kitamura K: Immunological study of late cerebral vasospasm in subarachnoid hemorrhage. Detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immunofluorescence method. Neurol Med Chir (Tokyo) 24: 647-654, 1984
37. Mayberg MR, Hauser OW, Sundt TM Jr: Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage. J Neurosurg 48: 49-57, 1978
38. Peerless SJ, Kendall MJ: Cerebral vasospasm. Experimental cerebral vasospasm. In Whisnant JP, Sandok BA (eds): Proceedings of the Ninth Princeton Conference on Cerebral Vascular Disease. New York, Grune & Stratton, 1975, pp 49-58
39. Fraser RAR, Stein MM, Barrett RE. Pool JL: Noradrenergic mediation of experimental cerebrovascular spasm. Stroke 1: 356-362, 1970
40. Owman C, Edvinsson L, Sahlin C, Svendgaard NA: Transmitter changes in peri vascular sympathetic nerves after experimental subarachnoid hemorrhage. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980. pp 279-283
41. Yoshioka J, Clower BR, Smith RR: The angiopathy of subarachnoid hemorrhage. I. Role of vessel wall catecholamines. Stroke 15: 288-294, 1984
42. Lobato RD, Marin J, Salaices M, Burgos J, Rivilla F, Garcia AG: Effect of experimental subarachnoid hemorrhage on the adrenergic innervation of cerebral arteries. J Neurosurg 53: 477-479, 1980
43. Lobato RD, Marin J, Salaices M, Rivilla F, Burgos J: Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage. J Neurosurg 53: 480-485, 1980
44. Fisher CM, Kistler JP, David JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9, 1980
45. Mizukami M. Takemae T, Kin H, KawaseT, Araki G: Computed tomography of ruptured intracranial aneurysm in acute stage - relationship between vasospasm and high density on CT scan. Brain and Nerve (Tokyo) 30: 861-866, 1978
46. Mizukami M, Takemae T, Tazawa T, Kawase T, Matsuzaki T: Value of computed tomography in the prediction of cerebral vasospasm after aneurysmal rupture. Neurosurgery 7: 583-586. 1980
47. Symon L, Bell BA, Kendall B: Relationship between effused blood and clinical course and prognosis in aneurysmal subarachnoid hemorrhage: A preliminary computerized tomography scan study. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 409-411
48. Saito I, Sano K: Vasospasm following rupture of cerebral aneurysms. Neurol Med Chir (Tokyo) 19: 103-107. 1979
49. Suzuki J, Komatsu S, Sato T, Sakurai Y: Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid hemorrhage. Acta Neurochir (Wien) 55: 63-70, 1980
50. Kistler JP, Crowell RM, Davis KR, Heros R. Ojemann RG, Zervas T, Fisher CM: The relation of cerebral vasospasm to the extent and reaction of subarachnoid blood visualized by CT scan: A prospective study. Neurology (NY) 33 (4): 424-436, 1983
51. Kagstrom E, Palma L: Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 48: 257, 1972
52. Schisano G: The use of antifribinolytic drugs in aneurysmal subarachnoid hemorrhage. Surg Neurol 10: 217-222, 1978
53. Kassel l NF, Torner JC, Adams HP: Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. J Neurosurg 61: 225-230, 1984
54. Saito I, Ueda Y, Sano K: Significance of vasospasm in the treatment of ruptured intracranial aneurysms. J Neurosurg 47: 412-429, 1977
55. Sano K, Saito I: Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm. Acta Neurochir (Wien) 41: 49-60. 1978
56. Suzuki J. Yoshimoto T, Onuma T: Early operations for ruptured intracranial aneurysms - Study of 31 cases operated on within first four days after ruptured aneurysm. Neurol Med Chir (Tokyo) 18: 83-89, 1978
57. Sasaki T, Asano T, Takakura K, Sano K, Kassell NF: Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage. J Neurosurg 60: 1186-1191, 1984
58. Nielsen KC. Owman C: Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res 27: 33-42, 1971
59. Allen GS, Henderson LM, Chou SN, French LA: Cerebral arterial spasm. Part 1: In vitro contraction of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg 40: 433-441, 1974
60. Allen GS, Gross CJ: Cerebral arterial spasm Pan 7: In vitro effects of alpha adrenergic agents on canine arteries from six anatomical sites and six blocking agents on serotonin-induced contractions of the canine basilar artery. Surg Neurol 6: 63-70, 1976
61. Zervas NT, Lavyne MH. Negoro M: Neurotransmitters and the normal and ischemic cerebral circulation. N Engl J Med 293: 812-816, 1975
62. Toda N: Influence of dopamine and norepinephrine on isolated cerebral arteries of the dog. Br J Pharmacol 58: 121-126, 1976
63. Toda N: Alpha adrenergic receptor subtype in human, monkey and dog cerebral arteries. J Pharmacol Exp Ther 226: 861-868, 1983
64. Raynor RB. McMurtry JG, Pool JL: Cerebrovascular effects of topically applied serotonin in the cat. Neurology (Minneap) 11: 190-195, 1961
65. Kapp J, Mahaley MS, Odom GL: Cerebral arterial spasm. Part 2: Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg 29: 339-349, 1968
66. 2α, serotonin and norepinephrine on cerebrovascular tone of monkey. Eur J Pharmacol 15: 300-309, 1971
67. Allen GS, Gold LHA, Chou SN, French LA: Cerebral arterial spasm. Part 3: In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine. J Neurosurg 40: 451-458, 1974
68. White RP, Hagen AA, Morgan H, Dawson WN, Robertson JT: Experimental study on the genesis of cerebral vasospasm. Stroke 6: 52-57, 1975
69. Miyaoka M, Nonaka T, Watanabe H, Chigasaki H, Ishii S: Etiology and treatment of prolonged vasospasm: Experimental and clinical studies. Neurol Med Chir (Tokyo) 16: 103-114, 1976
70. Osaka K: Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurgery 47: 403-411, 1977
71. Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir (Wien) 44: 97-106, 1978
72. Ozaki N, Mullan S: Possible role of the erythrocyte in causing prolonged cerebral vasospasm. J Neurosurg 51: 773-778, 1979
73. Tanishima T: Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg 53: 787-793, 1980
74. Wellum GR, Irvine TW, Zervas NT: Cerebral vasoactivity of heme proteins in vitro: some mechanistic considerations. J Neurosurg 56: 777-783, 1982
75. White RP, Chapleau CE, Dugdale M, Robertson JT: Cerebral arterial contractions induced by human and bovine thrombin. Stroke 11: 363-368, 1980
76. Ito M: Experimental vasospasms - significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine. Neurol Med Chir (Tokyo) 20: 225-236, 1980
77. Forster C, Mohan J, Whalley ET: Interaction of fibrin degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations: possible role in cerebral vasospasm. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 186-189
78. 2α on the basilar artery of cats. Surg Neurol 2: 251-255, 1974
79. 2α in the cat. J Neurosurg 44: 173-175, 1976
80. Morgan H, White RP, Pennink M, Robertson JT: Prostaglandins and experimental cerebral vasospasm. Surg Forum 23: 447-448, 1972
81. Yamamoto YL, Feindel W, Wolfe LS, Katoh H, Hodge CP: Experimental vasoconstriction of cerebral arteries by prostaglandins. J Neurosurg 37: 385-397, 1972
82. Rosenblum WI: Effects of prostaglandins on cerebral blood vessels: Interaction with vasoactive amines. Neurology (Minneap) 25: 1169-1171, 1975
83. 2 to vasoconstrictions induced by various prostaglandins, serotonin and hemoglobin using the canine basilar artery. Neurol Med Chir (Tokyo) 22: 507-512, 1982
84. 2. Stroke 8: 480-482, 1977
85. 2 and verapamil in isolated arteries. Cir Res 51: 675-682, 1982
86. Sasaki T, Kassell NF, Tomer JC, Maixner W, Turner D: Pharmacological comparison of isolated monkey and dog cerebral arteries. Stroke, 1985 (in press)
87. 2 on isolated human cerebral arteries. Acta Neurochir (Wien) 62: 177-185. 1982
88. Sasaki T, Wakai S, Asano T, Watanabe T, KirinoT. Sano K: The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 54: 357-365, 1981
89. Sasaki T, Asano T, Sano K: Cerebrl vasospasm and free radical reactions. Neurol Med Chir (Tokyo) 20: 145-153. 1980
90. Koide T, Noda Y, Hata S, Sugioka K, Kobayashi S, Nakano M: Contraction of the canine basilar artery following lineoleic, arachidonic. 13-hydroperoxylineoleic, or 15-hydroperoxyarachidonic acid (41294). Proc Soc Exp Biol Med 168: 399-402, 1981
91. Asano T, Tanishima T, Sasaki T, Sano K: Possible participation of free radical react ions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 190-201
92. Sano K: Cerebral vasospasm and aneurysm surgery. Clin Neurosurg 30: 13-58. 1983
93. Toda N: Responsiveness to potassium and calcium ions of isolated cerebral arteries. Am J Physiol 227: 1206-1211, 1974
94. Wilkins RH. Levitt P. Potassium and the pathogenesis of cerebral arterial spasm in dog and man. J Neurosurg 35: 45-50, 1971
95. Shiguma M: Change in the ionic environment of cerebral arteries after subarachnoid hemorrhage. Especially of potassium ion concentration in subarachnoid hematoma and its role in cerebral vasospasm. Neurol Med Chir (Tokyo) 22: 805-812, 1982
96. Farrar JK Jr: Chronic cerebral arterial spasm: The role of intracranial pressure. J Neurosurg 43: 408-417, 1975
97. Johnston IH, Rowan JO. Haper AM, Jennett WB: Raised intracranial pressure and cerebral blood flow. J Neurol Neurosurg Psychiatry 35: 285-296, 1972
98. Farrar JK Jr, Roach MR: The effects of increased intracranial pressure on flow through major cerebral arteries in vitro. Stroke 4: 795-806, 1973
99. Beks JWF: Cerebral vasospasm and increased intracranial pressure. In Wilkins RH (ed). Cerebral Arterial Spasm, Baltimore, William & Wilkins, 1980, pp 412-413
100. Allen GS, Gross CJ, French LA, Chou SN: Cerebral arterial spasm. Part 5: In vitro contractile activity of vasoactive agents including human cerebrospinal fluid on human basilar and anterior cerebral arteries. J Neurosurg 44: 594-600, 1976
101. Boullin DJ, Mohan J, Grahame-Smith DG: Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 39: 756-766, 1976
102. Brandt L, Ljunggren B, Anderson KE, Hindfelt B, Teasdale G: Vasoconstrictive effects of human post-hemorrhagic cerebrospinal fluid on cat pial arterioles in situ. J Neurosurg 54: 351-356, 1981
103. Okwuasaba FK, Weir BKA, Cook DA, Krueger CA: Effects of various intracranial fluids on smooth muscle. Neurosurgery 9: 402-406, 1981
104. Sasaki T, Murota S, Wakai S, Asano T, Sano K: Evaluation of prostaglandin biosynthetic activity incanine basilar artery following subarachnoid injection of blood. J Neurosurg 55: 771-778, 1981
105. Maeda Y, Tani E, Miyamoto T: Prostaglandin metabolism in experimental cerebral vasospasm. J Neurosurg 55: 779-785, 1981
106. Walker V, Pickard JD, Smythe P, Eastwood S, Perry S: Effects of subarachnoid haemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 46: 119-125, 1983
107. Martin V, Villani GM, Jothianandan D, Furchgott RF: Selective blockade of endothelium dependent and glyceral-trinitrate induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232: 708-716, 1985
108. Furchgott RF, Cherry PO, Zawadzki JV, Jothianandan D: Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol 6: S336-S343, 1984
109. LiszczakTM, Varsos VG, Black P, Kistler JP, Zervas NT: Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 58: 18-26, 1983
110. Lee TJF, Mcllhany MP, Sarwinski S: Erythocyte extracts enhance neurogenic vasoconstriction of dog cerebral arteries in vitro. J Cereb Blood Flow Metab 4: 474-476, 1984
111. Fox PL, Dicoleto PF. Regulation of production of a PDGF-like protein by cultured bovine aortic endothelial cells. J Cell Phys 121: 298-308. 1984
112. Schwartz SM, Ross R: Cellular proliferation in atherosclerosis and hypertension. Progress in Cardiovascular Diseases 26: 355-372, 1984
113. Pelletieri L, Carlson CA, Lindholm L: Is the vasospasm following subarachnoid hemorrhage an immunoreactive disease? Experientia 15: 1170-1171, 1981
114. Ryan US: Immunological properties of endothelial cells. Journal of the Society for Artificial Internal Organs, 1985 (in press)
115. Ryan US: Endothelial cells and inflammation. Clinics in Laboratory Medicine 3 (4): 577-599, Dec. 1983
116. Weir BKA, Okwuasaba FK, Cook DA, Krueger CA: Pharmacology of Vasospasm-Effects of various agents including blood on isolated cerebral arteries. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, William & Wilkins, 1980, pp 237-243
117. Chyatte D, Sundt T: Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc 59: 498-505, 1984
118. Mizukami M, Kawase T, Tazawa T, Nagata K, Yunoki K, Yoshida Y: Hypothesis and clinical evidence for the mechanism of chronic cerebral vasospasm after subarachnoid hemorrhage. I Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 97-106
119. Yasargil MG. In Microneurosurgery Vol. 1. New York, Georg Thieme Verlag, 1984, p 344
120. Hughes JT, Schianchi PM: A histological study at necropsy of blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48: 515-525, 1978
121. Yamashita T, Yamamota S: Cerebral artery pathology in experimental subarachnoid hemorrhage. J Neurosurg 58: 843-850, 1983
122. Crompton MR: The pathogenesis of cerebral infarct ion following the rupture of cerebral berry aneurysms. Brain 87: 491-510, 1964
123. White RP: Multiple origins of cerebral vasospasm. In Cerebrovascular Diseases. Price TR, Nelson E (ed), New York, Raven Press, 1979, pp 307-319
124. White RP, Robertson JT: Comparison of piroxicam, medofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm. Neurosurgery 12: 40-46, 1983
125. Chyatte D, Rusch N, Sundt TM Jr. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. J Neurosurg 59: 925-932, 1983
126. Janoffa A, Carp H: Proteases, anti-proteases and oxidants: Pathways of tissue injury during inflammation. In Monographs in Pathology, vol 23. Majno G, Cotran R. Kaufman N (ed). Baltimore, Williams & Wilkins, 1982, pp 62-82
127. Cotran R: Endothelium and inflammation. In Monographs in Pathology, vol 23. Majno G, Cotran R, Kaufman N (ed), Baltimore, Williams and Wilkins, 1982, pp 18-37
128. Pinckard RN: The new chemical mediators of inflammation. In Monographs in Pathology, vol 23. Majno G, Cotran R, Kaufman N (ed), Baltimore, Williams & Wilkins. 1982, pp 38-52
129. Dujovny M, Kaufman HH, Kassosky N, Hurtelon MS, Miller M, Camel PC: Morphology of the subarachnoid space after subarachnoid hemorrhage in Wilkins RH (ed). Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 139-143
130. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M: Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 1985 (in press)
131. Fox JL, Ko JP: Cerebral vasospasm: A clinical observation. Surg Neurol 10: 269-275, 1978
132. Hirata Y, Matsukado Y, Fukumura A: Subarachnoid enhancement secondary to subarachnoid hemorrhage with special reference to the clinical significance and pathogenesis. Neurosurgery 11: 367-371, 1982
133. Tazawa T, Mizukami M, Kawase T, Usami T, Togashi O, Hyodo A, Eguchi T: Relationship between contrast enhancement on computed tomography and cerebral vasospasm in patients with subarachnoid hemorrhage. Neurosurgery 12: 643-648, 1983
134. Doczi T, Ambrose J, O’Laoire S: Significance of contrast enhancement in cranial computerized tomography after subarachnoid hemorrhage. J Neurosurg 60: 335-342, 1984
135. Holmsen H: Platelet secretion. In Hemostasis and Thrombosis. Colman R, Hirsh J (ed), Philadelphia, LP Lippincott, 1982, pp 390-403
136. Mustard JF, Kinlough-Rathbone R, Packham M: In Hemostasis and Thrombosis. Colman R, Hirsh J (ed), Philadelphia, LP Lippincott, 1982, pp 703-715
137. Garland CJ, Keatinge WR. Constrictive actions of ACH-5-HT and histamine on bovine coronary artery inner and outer muscle. J Physiol 327: 363-376, 1982
138. Peterson JW, Bun T, Cardia GJ, Ronner SF, Charn vis K, Zervas NT: Basilar arterial membrane is depolarized during cerebral vasospasm due to subarachnoid hemorrhage. Stroke 16 (1): 138, 1985 (abstr)
139. Grottendorst GR, Sippa HES, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet derived growth factor. Proc Nat Acad Sci 78: S669-S672, 1981
140. White RP, Robertson JT: Role of plasmin, thrombin and antithrombin as etiological factors in delayed cerebral vasospasm. Neurosurg 16 (1): 27-35, 1985
141. Boullin DJ: Assessment of animal models. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins. 1980, pp 291-293
142. White RP: Vasospasm. I. Experimental Findings. In Fox JL (ed): Intra-Cranial Aneurysms Vol I. Springer-Verlag, 1983, pp 218-249
143. Simeone FA, Vinal l PE: Evaluation of animal models of cerebral vasospasm. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 284-286
144. Fraser RAR. Cerebral vasospasm: After 15 years in the laboratory. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 187-210
145. Duff TA, Feilbach JA, Scott G: Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage. Stroke 16 (1): 142, 1985 (abstr)
146. Espinosa F, Weir B, Boisvert D, Overton T, Caston W. Chronic cerebral vasospasm after large subarachnoid hemorrhage in monkeys. J Neurosurg 57: 224-232, 1982
147. Peerless SJ. Fox AJ, Komatsu K, Hunter IG: Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys. Stroke 13: 473-479, 1982
148. Varsos VG, LiszczakTM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT: Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a “twohemorrhage” canine model. J Neurosurg 58: 11-17, 1983
149. Chyatte D, Sundt TM Jr: Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone. J Neurosurg 60: 923-926. 1984
150. Echlin FA: Vasospasm and focal cerebral ischemia. An experimental study. Arch Neurol Psychiat (Chicago) 47: 77-96, 1942
151. Wellum GR, Irvine TW, Zervas NT: Dose responses of cerebral arteries of the dog. rabbit, and man to human hemoglobin in vitro. J Neurosurg 53: 486-490, 1980
152. Hart MN: Morphometry of brain parenchymal vessels following subarachnoid hemorrhage. Stroke 11: 653-55, 1980
153. Baumbach GL, Heistad DD: Effect of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 52: 527-533, 1983
154. Grubb RL Jr, Raichle ME, Eichlins JO, Gado MH: Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. J Neurosurg 46: 446-453, 1977
155. Kassell NF, Boarini DJ: Timing of aneurysm surgery. In Neurosurgery, vol 2. Wilkins RH, Rengachary SS (ed). New York, McGraw Hill, 1985, pp 1363-1366
156. Pickard JD, Read DH, Lovick AHJ: Pre-operative assessment of cerebrovascular reactivity following subarachnoid hemorrhage - clinical correlations. Second International Symposium: “Cerebral Aneurysm Surgery in the Acute Stage”, Graz, Austria, Sept 1984, p 51 (abstr)
157. Kapp JP, Neill WR. Neill CL, Hodges LR, Smith RR: The three phases of vasospasm. Surg Neurol 18: 40-45, 1982
158. Suzuki S. Suzuki M. Iwabuchi T. Kamata Y: Role of multiple cerebral microthrombosis in symptomatic vasospasm - with a case report. Neurosurg 13 (2): 199-203. 1983
159. Linder M: Inhibition by dipyradimole of cerebral vasospasm induced in vitro by whole blood. J Neurosurg 58 (3): 352-5. 1983
160. Wilkins RH: Attempted prevention or treatment of intracranial arterial spasm: A survey. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore. Williams & Wilkins. 1980. pp 542-555
161. Mizukami M. Kawase T. Usami T. Tazawa T: Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10: 301-307. 1982
162. Tancda M. Effect of early operation for ruptured ancurysm on prevention of delayed ischemic symptoms. J Ncurosura 57: 622-628. 1982
163. Sano K. Saito I: Early operation and washout of blood clots for prevention of cerebral vasospasm. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore. Williams & Wilkins. 1980. pp 510-513
164. Peterson EW. Choo SH. Lewis AJ. Lach B. Bormanis J: Lysis of blood clot and experimental treatment of subarachnoid hemorrhage. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore. Williams & Wilkins. 1980. pp 625-627
165. Hashi K. Aoyama T. Nin K. ShimotakeT: Further trial of cisternal clot removal for severe subarachnoid hemorrhage. Second International Symposium. “Cerebral Ancurysm Surgery in the Acute Stage. ” Graz. Austria. Sept 1984. p 221 (abslr)
166. Drake CG: Management of cerebral ancurysm. Stroke 12: 273-283. 1981
167. Ohta H. Ito Z. Yasui N. Suzuki A: Extensive evacuation of subarachnoid clot for prevention of vasospasm… effective or not? Acta Neurochir (Wien) 63: 111-116. 1982
168. Ljunggren B. Brandt L. Kagstrom E. Sundbärg G: Results of early operations for ruptured aneurysms. J Neurosum 54: 473-479. 1981
169. Shiobara R. Kawase T. Toya S. Ebato K. Miyahara Y. “Scavcngery Surgery” for subarachnoid hemorrhage (II) - Continuous ventriculo-cisternal perfusion by use of artilicial ccrebrospinal fluid with urokinase. Second International Symposium, “Cerebral Aneurysm Surgery in the Acute Stage. ” Graz. Austria. Sept 1984. p 121 (abstr)
170. Salto I. Segawa H. Nagayama I. Kitamura K. Nihci H: Prevention of postoperative vasospasm by cisternal injection. Second International Symposium. “Cerebral Aneurysm Surgery in the Acute Stage. ” Graz. Austria. Sept 1984. p 171 (abstr)
171. Allen GS. Banghart SB: Cerebral arterial spasm: Part 9. In vitro effects of nifedipine on serotonin-, phcnylephrinc-. and potassium-induced contractions of canine basilar and femoral arteries. Neurosurgery 4: 37-42. 1979
172. Brandt L. Andcrsson KE. Edvinsson L. Ljunggren B Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries. J Cereb Blood Flow Metab 1: 339-347. 1981
173. KazdaS, Toward R: Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir (Wien) 63: 259-265, 1982
174. ++ antagonists than peripheral arteries. Stroke 11: 261-266. 1980
175. 2+ -induced contractions in isolated cerebral and peripheral arteries of the dog. Brit J Pharmacol 60: 35-43. 1977
176. McCalden TA. Bevan JA: Sources of activator calcium in the rabbit basilar artery. Am J Physiol 241: H129-H133. 1981
177. Auer LM, Ito Z. Suzuki A. Ohta H: Prevention of symptomatic vasospasm by topically applied nimodipine. Acta Neurochir (Wien) 63: 297-302. 1982
178. Barry KJ, Mikkelsen RB. Shucart W. Keough EM. Garvis V: Isolation and characterization of calcium-accumulating sub-cellular membrane fractions from cerebral arteries. J Neurosurg 62: 729-736, 1985
179. Allen GS, Ahn HS, Preziosi TJ. Battye R, Boone SC, Chou SN. Kelly DL, Weir BK, Crabbe RA. Lavik PJ. Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE. Bertsch LA, Boisvery DPJ, Hundley MB, Johnson RK. Strom JA. Transou CR: Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Mcd 308: 619-624. 1983
180. Towart R: The pathophvsiology of cerebral vasospasm. and pharmacological approaches to its management. Acta Neurochir (Wien) 63: 253-258. 1982
181. Levin RM. Weiss B: Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther 208: 454-459. 1979
182. Blaumanis OR. Grady PA: Experimental cerebral vasospasm: resolution by chlorpromazine. Sure Neurol 17: 263-268. 1982
183. Nakano M. Tani E. Fukumori T. Yokota M: Effects of chlorpromazine on experimental delayed cerebral vasospasm. J Neurosurg 61: 857-863. 1984
184. Peterson JW. Adams JF. Zervas NT: Calmodulin antagonism can prevent and relieve delayed cerebral vasospasm in two hemorrhage canine model. Fifty-Sixth Scientific Sessions of the American Heart Assoc. Anaheim Convention. Circulation 68 (sup 3): 171. 1983 (abstr)
185. Gavras H. Andrews P. Papadakis N: Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition. J Neurosurg 55: 884-888. 1981
186. Andrews P. Papadakis N. Gavras H: Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition. Stroke 13 (4): 480-483. 1982
187. Sasaki T. Wakai S. Asano T. Takakura K. Sano K: Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor OKY-1581. J Neurosurg 57: 74-82. 1982
188. Chan RC. Durity FA. Thompson GB. Nugent RA. Kendall M: The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61: 1120-1128. 1984
189. 2 synthetase on cerebral vasospasm after early surgery. J Neurosurg 61: 24-29. 1984
190. Quintana L. Kouda R. Ishibashi Y. Yoshimoto. Suzuki J: The effect of prostacyclin on cerebral vasospasm. An experimental study. Acta Neurochir (Wien) 62: 187-193. 1982
191. Fukumori T. Tani E. Maeda Y. Sukenaga A: Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm. J Neurosurg 59: 829-834, 1983
192. Hashi K. Matsuoka T. Tanaka K. Ohkawa N: Treatment of cerebral vasospasm with large doses of hydrocortisone. In Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore. Williams & Wilkins, 1980. pp 611-618
193. Oba M. Mizoi K. Fujimoto S. Yashimoto T. Suzuki J: Effect of posl ischemic administration of mannitol. Vitamin E. dexamethasonc and perfluorochemicals on cerebral ischemia. An experimental study. In Spetzler RF. Carter LP, Sel man WR. Martin NA (ed). Cerebral Revascularizatioit for Stroke. New York, Thieme Stratton 1985. pp 267-274
194. Kato Y. Sano H, Katada T. Kanno T: Experimental and clinical study in the use of intrathecal α-tocopherol in vasospasm. Second International Symposium, “Cerebral Aneurysm Surgery in the Acute Stage. ” Graz. Austria, Sept 1984. p 179 (abstr)
195. Dale J. Landmark KH. Myhre E: The effects of nifedipine. a calcium antagonist, on platelet function. Am Heart J 105: 103-105. 1983
196. Boulin DJ: Potential use of prostacyclin in the treatment of vasospasm. In Wilkins RH (ed) Cerebral Arterial Spasm, Baltimore. Williams & Wilkins, 1980, pp 533-539
197. Brown FD. Hanlon K, Mullan S: Treatment of aneurysmal hemiplegia with dopamine and mannitol. J Neurosurg 49: 525-529, 1978
198. Giannotta SL. McGillicuddy JE, Kindt GW: Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol 8: 286-290. 1977
199. Pritz MB, Giannotta SL. Kindt GW. McGillicuddy JE. Drager RL: Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 3: 364-368. 1978
200. McMurty JG, Pool JL. Nova HR: The use of rheomecrodex in the surgery of intracranial aneurysms. J Neurosurg 26: 218-222, 1967
201. Boscherstein FK, ReillyJA, Yahr MD, Correll JW: Effect of lowmolecular weight dextran on cortical blood flow. Arch Neurol 14: 288-293, 1966
202. Wood JH, SimeoneFA, Kron RE, Litt M: Rheological aspects of experimental hypervolemic hemodilution with low molecular weight dextran: relationship of cortical blood flow, cardiac output, and intracranial pressure to fresh blood viscosity and plasma volume. Neurosurgery 11: 739-753, 1982
203. Suzuki J, Yoshimoto T: The effect of mannitol in prolongation of permissible occlusion time of cerebral artery - clinical data of aneurysm surgery. Neurosurg Rev 1: 13-19, 1979
204. Little JR, Slugg RM, Latchaw JP Jr, Lesser RP: Treatment of acute focal cerebral ischemia with concentrated albumin. Neurosurgery 9: 552-558, 1981
205. Auer LM: Pial arterial vasbdilatation by intravenous nimodipine in cats. Drug Research 31: 1423-1425, 1981
206. Moncada S, Gryglewski R, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976
207. Boullin DJ, Bunting S, Blaso WP, Hunt TM, Moncada S: Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol 7: 139-147, 1979
208. Burke AM, Quest DO, Chien S, Cerri C: Effects of mannitol on blood viscosity. J Neurosurg 55: 550-553, 1981
209. Kee DB, Wood JH: Rheology of the cerebral circulation. Neurosurg 15: 125-131, 1884
210. Heyman A, Saltzman HA, Whalen RE: The use of hyperbaric oxygenation in the treatment of cerebral ischemia and infarction Circ 33/34 (suppl): 20-27, 1966
211. Handa H, Nagasawa S, Yonekawa Y, Narvo Y, Oda Y: New treatment of cerebral vasospasm with fluosol-Da 20%: Protective effect on cerebral ischemia and change of cerebral blood flow (CBF). Prog Cir Biol Res 122: 299-306, 1983
212. Naito R, Yokoyama K: Physical and chemical properties of fluosol-DA after mixing with annex solutions. In Naito F, Yokoyama K (eds): Perfluorochemical Blood Substitutes. Osaka, Japan, Green Cross Corporation, 1978, pp 73-79
213. Tranmer BI, Gross CE, Kindt GW, Adey GR: The effect of pulsatile versus non-pulsatile blood flow in the treatment of ischemic stroke. Surg Forum, 1985 (in press)
214. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11: 337-343, 1982
215. Flower RG: Macrocortin and the antiphospholipase proteins. In Weissman G (ed) Advances in Inflammation Research, vol 8, New York, Raven Press, 1984, pp 1-34
216. Schanne FAX, Kane AB, Young EE, Farber JL: Calcium dependence of toxic cell death: a final common pathway. Science 206: 700-702, 1979
217. Kassell NF, Peerless SJ, Drake CG, Boarini DJ, Adams HP: Treatment of ischemic deficits from cerebral vasospasm with high dose barbiturate therapy. Neurosurg 7: 593-597, 1980